Apeloa Pharmaceutical Hits Day High with Strong 6.7% Intraday Surge

Apeloa Pharmaceutical Co., Ltd. has experienced a significant uptick in its stock performance, gaining 6.7% on June 29, 2026. The stock reached an intraday high of CNY 17.20, showcasing its notable activity in the market. This performance stands in contrast to the China Shanghai Composite, which only increased by 1.16% on the same day. Over the past week, Apeloa has shown a 4.03% increase, while the broader market index declined by 2.14%. In the longer term, the company has delivered a 21.21% rise over the past year, outperforming the Shanghai Composite's 18.97% gain. However, the stock's performance over three and five years has been less favorable, with declines of 1.16% and 42.95%, respectively. Despite these fluctuations, Apeloa maintains a market capitalization of CNY 18,678 million and a price-to-earnings ratio of 21.00. The company also offers a dividend yield of 3.70%. While recent gains are noteworthy, the company has faced challenges, including negative results for the last six consecutive quarters and modest growth rates in net sales and operating profit over the past five years.